Delivery Order SPE2DB24D3013-SPE2DB24FFHQZ

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price of $2,033.85 and a completion date of January 10, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract award, valued at $1,176.75, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 100S. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it has an ultimate completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,775.99, is a Delivery Order with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA). The contract is for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a medication used in the treatment of various medical conditions. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,673.08, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of December 13, 2023. The award is not designated with a set-aside. Amerisourcebergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a prescription medication. It is a firm fixed price delivery order with a ceiling value of $2,874.49 and a period of performance through June 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,955.29, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. It is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of February 14, 2025. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Firm Fixed Price Delivery Order valued at $2,960.34. The contract is for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a medication, to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of July 7, 2025 and was awarded on July 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a ceiling value of $4,158.77 and a completion date of February 7, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $2,879.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules, with a performance period extending to April 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 500S, a generic medication, with a ceiling value of $2,175.00 and a performance period ending on May 13, 2025. The contract is a delivery order, priced on a firm fixed price basis, and does not have a set-aside designation, indicating open competition....
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFHQZ
    Delivery Order

This federal contract award, valued at $15,804.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a medication, to support military treatment programs and facilities. The contract has a firm fixed-price pricing type and an ultimate completion date of September 10, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This contract is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at up to $999,999,999 and runs through December 2025. These IDCs enable the DLA to efficiently procure essential pharmaceutical and medical supplies from Amerisourcebergen to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 12/9/24, 2:16 PM